Dialysis showdown: citrate vs heparin for bleeding risk patients
NCT ID NCT03562754
First seen Jan 09, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This study tested two ways to prevent blood clots during dialysis in 60 patients who were at risk of bleeding. One method used a substance called citrate, the other used a low dose of heparin. The goal was to see which approach allowed dialysis to last longer and caused fewer bleeding problems. Results help doctors choose the safer option for these vulnerable patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Nimes
Nîmes, 30029, France
Conditions
Explore the condition pages connected to this study.